Tinti et al published data in 2019 from a case series involving the use of MDG in 3 children with T1D and impending or mild hypoglycemia (4 episodes) who refused oral carbohydrate.12 Mini-dose glucagon was given at a dose of 10 μg subcutaneously for every year of age up to a maximum of 150 μg. This evidence concerns the gene GCG and Hypoglycemia.